{"name": "Thrasos",
 "permalink": "thrasos",
 "crunchbase_url": "http://www.crunchbase.com/company/thrasos",
 "homepage_url": "http://www.thrasos.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@thrasos.com",
 "phone_number": "514-940-2714",
 "description": "",
 "created_at": "Fri Oct 26 03:43:49 UTC 2012",
 "updated_at": "Mon Mar 25 04:34:25 UTC 2013",
 "overview": "\u003Cp\u003EThrasos is a bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company\u0026#8217;s lead therapeutic program, THR-184, is focused on the prevention and treatment of acute kidney injury (AKI). The Company also has a preclinical development program for treating chronic kidney disease (CKD).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],
     [[250,
       94],
      "assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],
     [[252,
       95],
      "assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Dr.",
      "last_name": "Andreas Orfanos",
      "permalink": "dr-andreas-orfanos",
      "image": null}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Richard",
      "last_name": "Andrews",
      "permalink": "richard-andrews",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Research and Development",
    "person":
     {"first_name": "Dr.",
      "last_name": "Philippe Bey",
      "permalink": "dr-philippe-bey",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase",
    "source_description": "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fonds de solidarit\u00e9 FTQ",
         "permalink": "fonds-de-solidarit-ftq",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/1164/61164v2-max-150x150.png"],
             [[184,
               50],
              "assets/images/resized/0006/1164/61164v2-max-250x250.png"],
             [[184,
               50],
              "assets/images/resized/0006/1164/61164v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lumira Capital",
         "permalink": "lumira-capital",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0013/3918/133918v1-max-150x150.jpg"],
             [[228,
               81],
              "assets/images/resized/0013/3918/133918v1-max-250x250.jpg"],
             [[228,
               81],
              "assets/images/resized/0013/3918/133918v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GSK Canada Life Sciences Innovation Fund",
         "permalink": "gsk-canada-life-sciences-innovation-fund",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2000 Peel St.",
    "address2": "Suite 900",
    "zip_code": "H3A 2W5",
    "city": "Montreal, QC",
    "state_code": null,
    "country_code": "CAN",
    "latitude": 45.5009438,
    "longitude": -73.5750635}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}